Seven Mile Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Sell |
4,392
-168
| -4% | -$11.7K | 0.18% | 116 |
|
|
2025
Q1 | $335K | Buy |
4,560
+455
| +11% | +$33.4K | 0.22% | 97 |
|
|
2024
Q4 | $269K | Sell |
4,105
-67
| -2% | -$4.39K | 0.17% | 113 |
|
|
2024
Q3 | $325K | Buy |
4,172
+751
| +22% | +$58.5K | 0.22% | 93 |
|
|
2024
Q2 | $267K | Buy |
3,421
+378
| +12% | +$29.5K | 0.2% | 107 |
|
|
2024
Q1 | $206K | Buy |
+3,043
| New | +$206K | 0.16% | 148 |
|
|
2023
Q4 | – | Sell |
-3,665
| Closed | -$248K | – | 152 |
|
|
2023
Q3 | $248K | Buy |
3,665
+217
| +6% | +$14.7K | 0.26% | 91 |
|
|
2023
Q2 | $247K | Buy |
+3,448
| New | +$247K | 0.29% | 84 |
|